http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13921453

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 5
issn 0098-6151
issueIdentifier 3 Suppl 4
pageRange S11-5
publicationName The Journal of the American Osteopathic Association
startingPage S11
bibliographicCitation Sussman DO. Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors. J Am Osteopath Assoc. 2004 Mar;104(3 Suppl 4):S11–5. PMID: 15083994.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03557d59e5322d05e6662b1afb9475c7
date 200403
identifier https://pubmed.ncbi.nlm.nih.gov/15083994
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4029
https://portal.issn.org/resource/ISSN/0098-6151
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors
discusses http://id.nlm.nih.gov/mesh/M0020791
http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0014874
http://id.nlm.nih.gov/mesh/M0327633
http://id.nlm.nih.gov/mesh/M0016884
http://id.nlm.nih.gov/mesh/M0021908
http://id.nlm.nih.gov/mesh/M0018169
http://id.nlm.nih.gov/mesh/M0387384
http://id.nlm.nih.gov/mesh/M0011048
http://id.nlm.nih.gov/mesh/M0016659
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010726Q000494
http://id.nlm.nih.gov/mesh/D007172Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004347
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D010879Q000494
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D002318Q000150
http://id.nlm.nih.gov/mesh/D011687
http://id.nlm.nih.gov/mesh/D013450
http://id.nlm.nih.gov/mesh/D007093Q000494
http://id.nlm.nih.gov/mesh/D048909
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D009566Q000627
http://id.nlm.nih.gov/mesh/D000068677
http://id.nlm.nih.gov/mesh/D000959Q000627
http://id.nlm.nih.gov/mesh/D010726Q000493
http://id.nlm.nih.gov/mesh/D000069058
http://id.nlm.nih.gov/mesh/D007172Q000150
http://id.nlm.nih.gov/mesh/D014227
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110635
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8158
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9997
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.4.1
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135438569

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127542003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129223014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129612837

Total number of triples: 59.